microRNA-10a-5p overexpression suppresses malignancy of colon cancer by regulating human liver cancer fibroblasts.


Journal

Neoplasma
ISSN: 0028-2685
Titre abrégé: Neoplasma
Pays: Slovakia
ID NLM: 0377266

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 26 02 2021
accepted: 10 06 2021
pubmed: 18 9 2021
medline: 15 12 2021
entrez: 17 9 2021
Statut: ppublish

Résumé

The crosstalk between tumor and stroma plays a critical role in cancer metastasis. However, the function of miR-10a-5p on liver fibroblasts in the metastatic microenvironment of colon cancer (CC) and the effect of activated fibroblasts on CC cells are still unclear. In our study, miR-10a-5p overexpression inhibited the proliferation, migration, and IL-6/IL-8 level of LX-2 cells and human liver cancer fibroblasts (HLCFs). Moreover, miR-10a-5p had lower expression in HLCFs than in human liver normal fibroblasts (HLNFs). The conditioned medium (CM) from LX-2 cells with miR-10a-5p overexpression or HLNFs could inhibit the invasion, migration, and stemness of CC SW480 cells, whereas HLCFs CM could promote these malignant phenotypes of SW480 cells. The present study illustrates the effect of miR-10a-5p on the liver fibroblasts and the altered liver fibroblasts in the microenvironment on CC cells induced by miR-10a-5p, which may aid the understanding of the mechanisms underlying CC liver metastasis.

Identifiants

pubmed: 34533029
doi: 10.4149/neo_2021_210226N250
pii: 210226N250
doi:
pii:

Substances chimiques

MIRN10 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1157-1168

Auteurs

Xuan Zheng (X)

Nuclear Medicine Clinical Laboratory, Tangshan People's Hospital, Tangshan, Hebei, China.

Jing-Wu Li (JW)

The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, China.

Yan-Kun Liu (YK)

The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, China.

Yi-Fu Ma (YF)

Department of Radiology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Jian-Hui Gan (JH)

Department of Anesthesiology, Tangshan People's Hospital, Tangshan, Hebei, China.

Su-Gui Han (SG)

Nuclear Medicine Clinical Laboratory, Tangshan People's Hospital, Tangshan, Hebei, China.

Jian Wang (J)

Department of Gastrointestinal Surgery, Tangshan People's Hospital, Tangshan, Hebei, China.

Zhao-Yuan Wan (ZY)

The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, China.

Jun Zhang (J)

The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, China.

Yan Liu (Y)

The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, China.
College of Life Sciences, North China University of Science and Technology, Tangshan, Hebei, China.

Yu-Feng Li (YF)

The Cancer Institute, Tangshan People's Hospital, Tangshan, Hebei, China.

Guang-Ling Zhang (GL)

School of Clinical Medicine, North China University of Science and Technology, Tangshan, Hebei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH